Literature DB >> 9010318

Estrogen induction of TGF-alpha is mediated by an estrogen response element composed of two imperfect palindromes.

D El-Ashry1, S A Chrysogelos, M E Lippman, F G Kern.   

Abstract

To investigate the molecular mechanisms underlying the two- to three-fold induction of human transforming growth factor-alpha (hTGF-alpha) mRNA and two- to five-fold induction of hTGF-alpha protein observed following estrogen treatment of hormone-responsive human breast cancer cell lines, the hTGF-alpha promoter was assayed for ERE-like sequences able to mediate estrogen induction of a heterologous gene. Transient co-transfection of a chloramphenicol acetyl transferase (CAT) construct consisting of either 1100 bp or 330 bp of hTGF-alpha promoter sequence and an estrogen receptor expression vector into either COS-7 cells or hormonally responsive MCF-7 human breast cancer cells resulted in a two- to five-fold induction of CAT activity by estrogen. Although no consensus estrogen response element (ERE) exists in the hTGF-alpha promoter, a sequence consisting of two imperfect ERE palindromes separated by 20 bp is located at -200 to -252. This sequence was inserted into a mouse mammary tumor virus (MMTV) based CAT construct and assayed for its ability to confer estrogen regulation of CAT expression to a heterologous promoter. Transient co-transfection of this construct with an estrogen receptor expression vector into either COS-7 cells or MCF-7 cells resulted in an average 30-fold estrogen induction of CAT activity. Gel shift assays with human recombinant estrogen receptor (ER) and 32P-labelled fragments revealed that the ER could specifically bind to this sequence. These results indicate that this 53 bp sequence can function as an ERE, and is likely to be responsible for the observed induction of TGF-alpha message and protein in response to estrogen. These data also indicate that the level of estrogen inducibility mediated by this element may be positively or negatively modulated by interaction or competition with other transcription factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9010318     DOI: 10.1016/s0960-0760(96)00118-5

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  19 in total

1.  TGF-alpha exerts biphasic effects on estrogen--and phytoestrogen-mediated gene expression in breast cancer cells.

Authors:  S T Willard; L S Frawley
Journal:  Endocrine       Date:  1999-08       Impact factor: 3.633

Review 2.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

3.  Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines.

Authors:  Thomas L Gonzalez; Rebecca K Moos; Christina L Gersch; Michael D Johnson; Rudy J Richardson; Holger M Koch; James M Rae
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

Review 4.  Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer.

Authors:  K Ted Thurn; Scott Thomas; Amy Moore; Pamela N Munster
Journal:  Future Oncol       Date:  2011-02       Impact factor: 3.404

5.  Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

Authors:  Jennifer H Gutzman; Sarah E Nikolai; Debra E Rugowski; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2005-03-03

Review 6.  Mechanisms of gender-linked ischemic brain injury.

Authors:  Mingyue Liu; Suzan Dziennis; Patricia D Hurn; Nabil J Alkayed
Journal:  Restor Neurol Neurosci       Date:  2009       Impact factor: 2.406

Review 7.  The p53-estrogen receptor loop in cancer.

Authors:  C Berger; Y Qian; X Chen
Journal:  Curr Mol Med       Date:  2013-09       Impact factor: 2.222

8.  Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations.

Authors:  Stephanie L Nott; Yanfang Huang; Xiaodong Li; Brian R Fluharty; Xing Qiu; Wade V Welshons; Shuyuan Yeh; Mesut Muyan
Journal:  J Biol Chem       Date:  2009-03-24       Impact factor: 5.157

Review 9.  Stroke: understanding the differences between males and females.

Authors:  Melinda E Wilson
Journal:  Pflugers Arch       Date:  2013-03-16       Impact factor: 3.657

Review 10.  Gender and the injured brain.

Authors:  Kamila Vagnerova; Ines P Koerner; Patricia D Hurn
Journal:  Anesth Analg       Date:  2008-07       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.